Menu
English
Stock Code: 00512.HK

Information Disclosure

Home
Information Disclosure

Contact Us

Units 3302, 33/F, The Center, 99 Queen's Road Central, Hong Kong

ir@chinagrandpharm.com

www.chinagrandpharm.com

Pages Links

Company Profile

Investor Relations

Legal Statement

Recent News

GP (HK) Obtains Exclusive Development and Commercialization Rights of Improved New Drug for Anti-inflammatory and Pain Relief after Ophthalmology Surgery, Enriches Its Product Pipeline of High-Barrier Drugs in the Ophthalmology Sector

2021-6-4
GP (HK)’s Two Global Innovative RDC Products Usher in a New Breakthrough, TLX591-CDx Dosed the First Patient in Japan; And TLX591 was Approved for Phase III Clinical Trials in Australia

2021-6-4

© 2021. China Grand Pharmaceutical and Healthcare Holdings Limited All Rights Reserved.